Good Distribution Practices (GDP) Compliance report for Pharmaceutical Industry is a reflection of the commitment to quality and sound practices throughout the entire pharmaceutical supply chain. These practices are essential for ensuring product safety and quality when distributing across the supply chain, especially in the pharmaceutical industry.

Managing quality of medicines during distribution can be difficult. Each dosage form (tablets, syrups, injectables etc.) has its own specified shelf life and storage conditions meaning that not all medicines can be treated with the same protocols. Thus, the transport and storage requirements for these different forms vary significantly.

Cold chain products must be stored at a range of temperatures between 2 °C to 8 °C, requiring more care due to the possibility of quality control failure. The GDP guidelines apply to all people and outlets involved in any section of storage and distribution of pharmaceuticals from the manufacturer’s premises until they reach the customer or their representative.